Koster Markus, Ledergerber Katrin, Brändle Michael
Endocrinol Diabetes Metab Case Rep. 2025 Jul 24;2025(3). doi: 10.1530/EDM-25-0008. Print 2025 Jul 1.
A 38-year-old man was admitted because of transient somnolence. Five weeks previously, he had suffered a subarachnoid hemorrhage from a ruptured aneurysm of the anterior communicating artery (ACOM), which was treated by craniotomy and clipping. He had recovered well, although loss of short-term memory and a forehead paresis on the side of craniotomy persisted. Clinical examination on admission showed no new neurological deficits. Cerebral computed tomography with angiography revealed no bleeding or infarction and correctly positioned clips. Laboratory examination showed severe hypernatremia (179 mmol/L). The patient was admitted to the intensive care unit (ICU) and treated with oral fluids and 5% glucose intravenously. Remarkably, he denied being thirsty and had to be encouraged to drink. Urine osmolality quickly fell to 294 mOsm/kg, polyuria of up to 400 mL/h was measured, and serum sodium remained elevated. Therefore, diabetes insipidus (DI) was obvious. After application of desmopressin acetate, urine output dropped to around 50 mL/h, confirming central DI or vasopressin deficiency (VD). Desmopressin acetate dose and volume management were continuously adjusted to blood sodium to restore euvolemia. Drinking volume needed to be supervised because of persistent lack of thirst and amnesia of being told to drink. Adipsic VD (aAVP-D) is a rare syndrome characterized by the combination of VD and loss of thirst in response to hypernatremia. It usually occurs within days after cell damage of osmoreceptors, for example after disruption of blood supply as in clipping of an ACOM aneurysm. Management includes titrated desmopressin acetate replacement, fixed water intake, weight monitoring, patient education and sodium monitoring.
Adipsic vasopressin deficiency (aAVP-D) is a rare form of vasopressin deficiency (VD) characterized by additional loss of thirst in response to hypernatremia due to impaired function of periventricular osmoreceptors. Bleeding from ACOM aneurysm and, possibly, therefore the performed frontal craniectomy with aneurysm clipping are the most frequent causes of aAVP-D. Other causes include craniopharyngioma, head trauma, germinoma or neurosarcoidosis. Management of aAVP-D includes replacement of titrated desmopressin acetate, fixed water intake, daily weight tracking, good patient education and regular sodium monitoring.
一名38岁男性因短暂嗜睡入院。五周前,他因前交通动脉(ACOM)动脉瘤破裂导致蛛网膜下腔出血,接受了开颅夹闭手术。尽管仍存在短期记忆丧失和开颅手术侧前额轻瘫,但他恢复良好。入院时的临床检查未发现新的神经功能缺损。脑部计算机断层扫描血管造影显示无出血或梗死,夹子位置正确。实验室检查显示严重高钠血症(179 mmol/L)。患者被收入重症监护病房(ICU),接受口服补液和静脉输注5%葡萄糖治疗。值得注意的是,他否认口渴,必须鼓励他饮水。尿渗透压迅速降至294 mOsm/kg,测得尿量高达400 mL/h,血清钠仍升高。因此,尿崩症(DI)明显。应用醋酸去氨加压素后,尿量降至约50 mL/h,证实为中枢性尿崩症或血管加压素缺乏(VD)。根据血钠情况持续调整醋酸去氨加压素的剂量和补液量,以恢复血容量正常。由于持续缺乏口渴感以及被告知饮水后失忆,需要监督其饮水量。失水性血管加压素缺乏症(aAVP-D)是一种罕见综合征,其特征是VD与高钠血症时口渴感丧失同时存在。它通常发生在渗透压感受器细胞受损后的数天内,例如在ACOM动脉瘤夹闭术中血供中断后。治疗包括滴定式醋酸去氨加压素替代、固定饮水量、体重监测、患者教育和血钠监测。
失水性血管加压素缺乏症(aAVP-D)是血管加压素缺乏症(VD)的一种罕见形式,其特征是由于室周渗透压感受器功能受损,对高钠血症时口渴感额外丧失。ACOM动脉瘤出血以及可能因此进行的额叶开颅夹闭动脉瘤手术是aAVP-D最常见的原因。其他原因包括颅咽管瘤、头部外伤、生殖细胞瘤或神经结节病。aAVP-D的治疗包括滴定式醋酸去氨加压素替代、固定饮水量、每日体重追踪、良好患者教育和定期血钠监测。